Abbott Receives CE Mark For Two New Uses Of Panbio COVID-19 Ag Rapid Test Device
NORTH CHICAGO (dpa-AFX) - Abbott (ABT) said it has received CE Mark for two new uses of its Panbio COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus: asymptomatic testing and self-swabbing.
Panbio COVID-19 Ag's label has been updated with clinical data on asymptomatic individuals, which enables mass testing (mass screening) of people who do not currently present symptoms of the disease.
Panbio Rapid Antigen Test is approved for use with a patient-friendly and minimally invasive nasal swab. Patients can self-administer sample collection under a healthcare professional's supervision, the company said.